Fact CheckerSign in

NCT05553847Completed

Automated Oxygen Titration in Daily Life in Patients With COPD on Home Oxygen

Automated Oxygen Titration to Improve Activities of Daily Living in Patients With Chronic Obstructive Pulmonary Disease on Home Oxygen

Source: ClinicalTrials.gov · Last updated 29 Nov 2023

Brief summary (registry, in English)

The purpose of this study is to examine the effect of automated oxygen titration compared to the usual fixed dose oxygen on the patient's ability to perform activities of daily living.

Status (registry)
Completed
Study type
Interventional
Enrollment
32 (actual)
First submitted
15 Sept 2022
Start date
30 Oct 2022
Primary completion date
14 Nov 2023
Lead sponsor
Hvidovre University Hospital
Diseases
COPD
NCT number
NCT05553847

What you commit to

  • Study type: Interventional
  • Participants enrolled: 32
  • From 30 Oct 2022 to the primary completion date, 14 Nov 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Exacerbation in COPD treated with either antibiotics or prednisolone within the last 3 weeks

Other illness

  • Pulmonary or cardiac condition other than COPD limiting physical performance
  • Unstable heart condition or stenotic aortic valve disease
  • A physical condition including paralysis, lower extremity pain, or back problem limiting physical performance

Who the study is looking for

  • Verified history of COPD with FEV1/FVC \< 0.70 and FEV1 \< 50 %
  • Hypoxemic at rest (SpO2≤ 90 %) and fulfilment of general national criteria for LTOT
    • Partial pressure of Oxygen (PaO2) (without oxygen supplement) ≤7.3 kPa in clinically stable and optimally treated condition
    • Increase in PaO2 after oxygen supplementation (to 8.0-9.0 kPa) without decrease in arterial pH (\> 0.03 kPa)
    • The oxygen is used at least 15 hours daily (optimally 24 hours daily)
    • The treatment is handled by hospital departments with lung medical expertise.
  • Able to walk at least 30 meters
  • Age \>18, Cognitively able to participate in the study and willing to give informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Copenhagen University Hospital - Hvidovre
Coordinator of this site? Confirm its status
HvidovreDenmarkUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.